相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Soluble CD83 Triggers Resolution of Arthritis and Sustained Inflammation Control in IDO Dependent Manner
Dmytro Royzman et al.
FRONTIERS IN IMMUNOLOGY (2019)
CD83 is a new potential biomarker and therapeutic target for Hodgkin lymphoma
Ziduo Li et al.
HAEMATOLOGICA (2018)
CD83 Antibody Inhibits Human B Cell Responses to Antigen as well as Dendritic Cell-Mediated CD4 T Cell Responses
Kuan Y. Wong et al.
JOURNAL OF IMMUNOLOGY (2018)
The levels of soluble forms of CD21 and CD83 in multiple sclerosis
Sajad Karampoor et al.
JOURNAL OF NEUROIMMUNOLOGY (2018)
CD83 is a new potential biomarker and therapeutic target for Hodgkin lymphoma
Ziduo Li et al.
HAEMATOLOGICA (2018)
Soluble CD83 Alleviates Experimental Autoimmune Uveitis by Inhibiting Filamentous Actin-Dependent Calcium Release in Dendritic Cells
Wei Lin et al.
FRONTIERS IN IMMUNOLOGY (2018)
A blood dendritic cell vaccine for acute myeloid leukemia expands anti-tumor T cell responses at remission
Jennifer L. Hsu et al.
ONCOIMMUNOLOGY (2018)
CD83 expression is essential for Treg cell differentiation and stability
Marina Doebbeler et al.
JCI INSIGHT (2018)
Soluble CD83 Inhibits T Cell Activation by Binding to the TLR4/MD-2 Complex on CD14+ Monocytes
Joe M. Horvatinovich et al.
JOURNAL OF IMMUNOLOGY (2017)
Identification of Somatic Mutations in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type by Massive Parallel Sequencing
Sylvain Mareschal et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2017)
Crystal Structure of the Extracellular Domain of the Human Dendritic Cell Surface Marker CD83
Christiane S. Heilingloh et al.
JOURNAL OF MOLECULAR BIOLOGY (2017)
NK cells are negatively regulated by sCD83 in experimental autoimmune uveitis
Wei Lin et al.
SCIENTIFIC REPORTS (2017)
The Major Immediate-Early Protein IE2 of Human Cytomegalovirus Is Sufficient to Induce Proteasomal Degradation of CD83 on Mature Dendritic Cells
Christiane S. Heilingloh et al.
Frontiers in Microbiology (2017)
A Kinetic Study of CD83 Reveals an Upregulation and Higher Production of sCD83 in Lymphocytes from Pregnant Mice
Katrin Regina Helene Packhaeuser et al.
FRONTIERS IN IMMUNOLOGY (2017)
Expression of soluble CD83 in plasma from early-stage rheumatoid arthritis patients is not modified by anti-TNF-α therapy
Anne-Mette Kristensen et al.
CYTOKINE (2017)
The multiple pathways to autoimmunity
Argyrios N. Theofilopoulos et al.
NATURE IMMUNOLOGY (2017)
Immunosuppressive human anti-CD83 monoclonal antibody depletion of activated dendritic cells in transplantation
T. A. Seldon et al.
LEUKEMIA (2016)
Thymic CD4 T cell selection requires attenuation of March8-mediated MHCII turnover in cortical epithelial cells through CD83
Julia von Rohrscheidt et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2016)
Ubiquitin ligase MARCH 8 cooperates with CD83 to control surface MHC II expression in thymic epithelium and CD4 T cell selection
Haiyin Liu et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2016)
The Analysis of CD83 Expression on Human Immune Cells Identifies a Unique CD83+-Activated T Cell Population
Xinsheng Ju et al.
JOURNAL OF IMMUNOLOGY (2016)
CD83 Modulates B Cell Activation and Germinal Center Responses
Lena Krzyzak et al.
JOURNAL OF IMMUNOLOGY (2016)
Mutations or copy number losses of CD58 and TP53 genes in diffuse large B cell lymphoma are independent unfavorable prognostic factors
Yang Cao et al.
ONCOTARGET (2016)
CD83 and GRASP55 interact in human dendritic cells
Marcello F. Stein et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)
Murine CD83-positive T cells mediate suppressor functions in vitro and in vivo
Simon Kreiser et al.
IMMUNOBIOLOGY (2015)
L Particles Transmit Viral Proteins from Herpes Simplex Virus 1-Infected Mature Dendritic Cells to Uninfected Bystander Cells, Inducing CD83 Downmodulation
Christiane S. Heilingloh et al.
JOURNAL OF VIROLOGY (2015)
Continuous expression of CD83 on activated human CD4+ T cells is correlated with their differentiation into induced regulatory T cells
Liwen Chen et al.
MOLECULAR MEDICINE REPORTS (2015)
Human T-cell leukemia virus type-I Tax induces the expression of CD83 on T cells
Yuetsu Tanaka et al.
RETROVIROLOGY (2015)
Dendritic cell CD83 homotypic interactions regulate inflammation and promote mucosal homeostasis
J. M. Bates et al.
MUCOSAL IMMUNOLOGY (2015)
Recurrent targets of aberrant somatic hypermutation in lymphoma
Alireza Hadj Khodabakhshi et al.
Oncotarget (2015)
Acute graft-versus-host disease: a bench-to-bedside update
Shernan G. Holtan et al.
BLOOD (2014)
Soluble CD83 inhibits human monocyte differentiation into dendritic cells in vitro
Hongyu Lin et al.
CELLULAR IMMUNOLOGY (2014)
Soluble CD83 ameliorates experimental colitis in mice
J. Eckhardt et al.
MUCOSAL IMMUNOLOGY (2014)
The Expression and Characterization of Functionally Active Soluble CD83 by Pichia pastoris Using High-Density Fermentation
Yugang Guo et al.
PLOS ONE (2014)
Soluble human CD83 ameliorates lupus in NZB/W F1 mice
Charlotte Starke et al.
IMMUNOBIOLOGY (2013)
Topical Application of Soluble CD83 Induces IDO-Mediated Immune Modulation, Increases Foxp3+ T Cells, and Prolongs Allogeneic Corneal Graft Survival
Felix Bock et al.
JOURNAL OF IMMUNOLOGY (2013)
Multiple Interferon Regulatory Factor and NF-κB Sites Cooperate in Mediating Cell-Type- and Maturation-Specific Activation of the Human CD83 Promoter in Dendritic Cells
Marcello F. Stein et al.
MOLECULAR AND CELLULAR BIOLOGY (2013)
Identification of human germinal center light and dark zone cells and their relationship to human B-cell lymphomas
Gabriel D. Victora et al.
BLOOD (2012)
CD83+ dendritic cells and Foxp3+ regulatory T cells in primary lesions and regional lymph nodes are inversely correlated with prognosis of gastric cancer
Seigo Kashimura et al.
GASTRIC CANCER (2012)
How I treat relapsed and refractory Hodgkin lymphoma
John Kuruvilla et al.
BLOOD (2011)
Activated T cells induce rapid CD83 expression on B cells by engagement of CD40
Birte Kretschmer et al.
IMMUNOLOGY LETTERS (2011)
CD83 increases MHC II and CD86 on dendritic cells by opposing IL-10-driven MARCH1-mediated ubiquitination and degradation
Lina E. Tze et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
CD83-stimulated monocytes suppress T-cell immune responses through production of prostaglandin E2
Liwen Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Eukaryotic expression of functionally active recombinant soluble CD83 from HEK 293T cells
Christine Staab et al.
IMMUNOBIOLOGY (2010)
Induction of Kidney Allograft Tolerance by Soluble CD83 Associated With Prevalence of Tolerogenic Dendritic Cells and Indoleamine 2,3-Dioxygenase
Zhu Lan et al.
TRANSPLANTATION (2010)
Immunosuppression Involving Soluble CD83 Induces Tolerogenic Dendritic Cells That Prevent Cardiac Allograft Rejection
Wei Ge et al.
TRANSPLANTATION (2010)
Prevention of Chronic Renal Allograft Rejection by Soluble CD83
Zhu Lan et al.
TRANSPLANTATION (2010)
CD83 polymorphisms and cervical cancer risk
Kelly J. Yu et al.
GYNECOLOGIC ONCOLOGY (2009)
Antibody to the dendritic cell surface activation antigen CD83 prevents acute graft-versus-host disease
John Wilson et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Engagement of CD83 on B Cells Modulates B Cell Function In Vivo
Birte Kretschmer et al.
JOURNAL OF IMMUNOLOGY (2009)
Release and clinical significance of soluble CD83 in chronic lymphocytic leukemia
B. D. Hock et al.
LEUKEMIA RESEARCH (2009)
Dendritic cell CD83: A therapeutic target or innocent bystander?
Charlene M. Prazma et al.
IMMUNOLOGY LETTERS (2008)
CD83 expression in CD4+ T cells modulates inflammation and autoimmunity
Simone Reinwald et al.
JOURNAL OF IMMUNOLOGY (2008)
Expression profiling reveals specific gene expression signatures in gastric MALT lymphomas
Minh Quang Huynh et al.
LEUKEMIA & LYMPHOMA (2008)
The CD83 reporter mouse elucidates the activity of the CD83 promoter in B, T, and dendritic cell populations in vivo
Matthias Lechmann et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
CD83 regulates lymphocyte maturation, activation and homeostasis
Minka Breloer et al.
TRENDS IN IMMUNOLOGY (2008)
Expression of a dendritic cell maturation marker CD83 on tumor cells from lung cancer patients and several human tumor cell lines: is there a biological meaning behind it?
R. B. Baleeiro et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2008)
CD83 expression is a sensitive marker of activation required for B cell and CD4+ T cell longevity in vivo
Charlene M. Prazma et al.
JOURNAL OF IMMUNOLOGY (2007)
CD83: an update on functions and prospects of the maturation marker of dendritic cells
Alexander T. Prechtel et al.
ARCHIVES OF DERMATOLOGICAL RESEARCH (2007)
Differential gene expression patterns and interaction networks in BCR-ABL-positive and -negative adult acute lymphoblastic leukemias
Dejan Juric et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
A limited course of soluble CD83 delays acute cellular rejection of MHC-mismatched mouse skin allografts
Jun-Fa Xu et al.
TRANSPLANT INTERNATIONAL (2007)
CD83 expression on dendritic cells and T cells: Correlation with effective immune responses
Cindy Aerts-Toegaert et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2007)
CD83 Modulates B Cell Function In Vitro: Increased IL-10 and Reduced Ig Secretion by CD83Tg B Cells
Birte Kretschmer et al.
PLOS ONE (2007)
Glucocorticoid use, other associated factors, and the risk of tuberculosis
SS Jick et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2006)
Levels of the soluble forms of CD80, CD86, and CD83 are elevated in the synovial fluid of rheumatoid arthritis patients
BD Hock et al.
TISSUE ANTIGENS (2006)
Alternative splicing generates putative soluble CD83 proteins that inhibit T cell proliferation
D Dudziak et al.
JOURNAL OF IMMUNOLOGY (2005)
CD83 is a dimer: Comparative analysis of monomeric and dimeric isoforms
M Lechmann et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
CD83 localization in a recycling compartment of immature human monocyte-derived dendritic cells
E Klein et al.
INTERNATIONAL IMMUNOLOGY (2005)
CD83 is preformed inside monocytes, macrophages and dendritic cells, but it is only stably expressed on activated dendritic cells
WP Cao et al.
BIOCHEMICAL JOURNAL (2005)
The soluble form of CD83 is present at elevated levels in a number of hematological malignancies
BD Hock et al.
LEUKEMIA RESEARCH (2004)
Differential up-regulation of HLA-DM, invariant chain, and CD83 on myeloid and plasmacytoid dendritic cells from peripheral blood
J Gómez et al.
TISSUE ANTIGENS (2004)
Activation of arterial wall dendritic cells and breakdown of self-tolerance in giant cell arteritis
W Ma-Krupa et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Prevention and treatment of experimental autoimmune encephalomyelitis by soluble CD83
E Zinser et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
The soluble form of CD83 dramatically changes the cytoskeleton of dendritic cells
N Kotzor et al.
IMMUNOBIOLOGY (2004)
Infection of mature monocyte-derived dendritic cells with human cytomegalovirus inhibits stimulation of T-cell proliferation via the release of soluble CD83
B Sénéchal et al.
BLOOD (2004)
Homologs of CD83 from elasmobranch and teleost fish
Y Ohta et al.
JOURNAL OF IMMUNOLOGY (2004)
Latent membrane protein 1 of Epstein-Barr virus induces CD83 by the NF-κB signaling pathway
D Dudziak et al.
JOURNAL OF VIROLOGY (2003)
Varicella-Zoster virus productively infects mature dendritic cells and alters their immune function
G Morrow et al.
JOURNAL OF VIROLOGY (2003)
Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase
DH Munn et al.
SCIENCE (2002)
Cloning and characterization of the promoter region of the human CD83 gene
S Berchtold et al.
IMMUNOBIOLOGY (2002)
CD83 expression influences CD4+ T cell development in the thymus
Y Fujimoto et al.
CELL (2002)
The extracellular domain of CD83 inhibits dendritic cell-mediated T cell stimulation and binds to a ligand on dendritic cells
M Lechmann et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
A soluble form of CD83 is released from activated dendritic cells and B lymphocytes, and is detectable in normal human sera
BD Hock et al.
INTERNATIONAL IMMUNOLOGY (2001)
CD83 is a sialic acid-binding Ig-like lectin (Siglec) adhesion receptor that binds monocytes and a subset of activated CD8+ T cells
N Scholler et al.
JOURNAL OF IMMUNOLOGY (2001)
Activation-induced expression of murine CD83 on T cells and identification of a specific CD83 ligand on murine B cells
SO Cramer et al.
INTERNATIONAL IMMUNOLOGY (2000)
Mature dendritic cells infected with herpes simplex virus type 1 exhibit inhibited T-cell stimulatory capacity
M Kruse et al.
JOURNAL OF VIROLOGY (2000)
分享论文
